Outcome of radiation monotherapy for high-risk patients with stage I esophageal cancer

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Currently, chemoradiation is the most widely used nonsurgical treatment for esophageal cancer. However, some patients, particularly the very elderly or those with severe vital organ dysfunction, face difficulty with the chemotherapy component. We therefore examined the outcome of radiation therapy (RT) alone for patients with esophageal cancer at our facility. Between January 2005 and December 2014, 84 patients underwent RT at our hospital, and 78 of these patients received concomitant chemotherapy. The remaining 6 patients underwent RT alone; these patients were considered to be high-risk and to have no lymph node metastasis (stage I). Five of them received irradiation up to a curative dose: 4 showed a complete response (CR) and 1 showed a partial response (PR). Of the patients exhibiting CR, 3 are currently living recurrence-free, whereas 1 patient underwent endoscopic submucosal dissection (ESD) as salvage therapy for local recurrence, with no subsequent recurrence. High-risk stage I esophageal cancer patients can be treated radically with RT alone under certain conditions. In the future, to broaden the indications for RT monotherapy to include some degree of advanced cancers, a novel concurrent therapy should be identified.

Original languageEnglish
Pages (from-to)127-133
Number of pages7
JournalActa medica Okayama
Volume71
Issue number2
Publication statusPublished - 2017

Keywords

  • Esophageal cancer
  • High-risk patient
  • Radiation therapy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Outcome of radiation monotherapy for high-risk patients with stage I esophageal cancer'. Together they form a unique fingerprint.

Cite this